Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
well I'm in, hoping for the best
20,810 sh. x .085
have jacuzyy change his name to jacuzzi.
0
but aiming for a few thousand.
Who makes the machines? ("Magna-techs", right?)
Are they custom design, or are they pre-existing devices used in other or related fields? Or are they pre-existing devices adapted to CTDT's method, or cobbled together from mostly pre-existing devices?
Wonder what else field-collapse could do, synthesis-wise?
I seem to recall news about a boron-nitride compound reputedly harder than diamond. Also, a mention elsewhere about a new diamond crystal morphology harder than the regular stuff.
Over the years, advances in diamond synthesis easily made coverage on the main media networks. I remember when the invention of vapor deposition--or some better version thereof--made it on CNN (I think it was CNN).
A few years ago a documentary on a cable channel detailed a company in Florida (?) doing it the new-old-fashioned-way with C precipitating and crystallizing out of pressurized molten metal.
You'd think Snaper's almost-magical field-collapse technique would draw network science divisions like flies.
Have been going through the messages here from May 1st on... which explains my previous non sequitir-ish replies.
CTDT... verrry interresting, but *not* stupid!
Found CTDT just combing through low-pricers in a stock screener. Nice chart. A bit squirrely intraday but the tech story is undeniable. Looking for a good entry point here.
So this expected PR... will be presumably about new equipment acquisition?
Was it "Mongol" or "Mongo"? ...
Hiked and fished in the Bighorns in WY. Yup, incredible landscapes and climate.
" At least 12 drug products have already applied for breakthrough product designation status, Woodcock said, raising the prospect that companies will soon have a better sense of whether FDA would feel comfortable approving such a drug without the usual standards of evidence."
hmmmm...
This is unreal! And I mean that in the good way.
That's right around nineteen square miles. About 190 million barrels at least.
.10000 HOD
I dunno... 20 square miles of 10mmbl/sq.mi. (at least) leasing rights is a pretty good reason.
With low-price stocks, there is always pumping. The catch is knowing what kind of dumping is going on, and who's doing it.
USGS estimates North Dakota and Montana have 7.4 billion barrels of recoverable oil reserves.
http://www.bloomberg.com/news/2013-04-30/bakken-three-forks-has-more-oil-than-2008-estimate-usgs.html
This seems to highlight western ND and NE Montana, however.
praying for a ten-bagger here
"This means Hyperdynamics has cash on the balance sheet – it ended 2012 with a cash balance of US$55 million – as well as a fully funded role
in up to two high impact wildcats,
with the first set to spud within 12 months."
.0074 ... hehheh, that's my current average.
Seems to be an effort to put the NVLX iHub board in the top ranks of most-posted boards, while at the same time present concentrated DD for new eyes.
I suspect this is for synergy with technical indicators that are across-the-board positive for NVLX at the moment.
It does underscore the growing popularity and influence of iHub in the investing world. Eh, let it roll.
I wish they'd do the same for HDY and JCDS, hehheh. ;)
An idea: Someone here most knowledgeable about JCDS might consider posting a contributing article to the Trefis Team website.
Trefis was founded by a group of MIT engineers and Wall Street analysts. They recently accepted and last Monday posted/published a contribution from a Forbes-contributing analyst regarding a penny biotech of which I hold 15k shares.
The article should be a sober balancing of potential and risks, and why JCDS is worth a look despite being a sub-penny. Results of DD (interviews, etc) are de rigueur.
Trefis may not accept it. Could be worth a try, though.
dollarland? that would be an almost half-billion dollar market cap. let's not get crazy here. (unless things *do* get crazy...)
forming a channel?... bottom trend starting around Mar 8?
Exactly. I *don't* "believe fully".
sorry, I'm tapped ;)
Instead of handing out thousands to turn-key publicity outfits, Nuvilex could probably get just as much or better PR benefit with a few well-made Youtube videos.
I hope you folks know what you are talking about, and that the DD I've found here is as unassailable as it looks.
I haven't bet the farm on JCDS, or even the plow. But a sub-penny is a sub-penny, money is money, and subpenny-to-multipenny stories are too far and few between.
A stock-buyback would be an epic development, indeed. But I'm not going to hold my breath.
well i'm in for ~.05% of the float, and in the green to boot.
Ah, forget it; dumb question anyway.
I am more or less sold. Bid is in.
JCDS
Interesting. Subpenny, but serious DD on its IH page shows it could be one of those fractional rarities on the up-and-up.
noob here. good untenable or bad untenable?
reposting
'Still sorting through the DD here. Very intrigued.
Have any of the DD'rs on this board gotten a sense of what gives JSDS's software an edge over (or at least a competitive equivalency with) the more established support-software makers?'
Interesting chart currently, notably the weekly chart. Watch for thinning volume.
HPOL ! Weekly chart looks booshable.
http://stockcharts.com/h-sc/ui?s=HPOL
Looks like a nice breakout out of snakey-looking ascending triangle. In at 1.10. Growing but subsidy-supported market so I'm optimistically wary.
My other holdings: HDY, ULUR, NVLX.
NVLX
I just got into it for the extraordinary potential, and good results phases I and II.
Large outstanding for a penny biotech however. Do your DD, well duh.
One thing they're definitely good at is making promises on performance that take much longer panning out or never do.
In it for the long haul for basically chickenfeed.
I like this from the recent update:
"It is the Company's objective to have Altrazeal® marketed in over 15 markets by year-end 2013... the Company anticipates that it will generate both positive cash flow and EBITDA for the fourth quarter 2013.
"Also, given the successful roll-out of Altrazeal®, the Company believes it will not be necessary to raise additional capital beyond the capital that has been already committed to the Company.
"Kerry P. Gray, President and CEO of ULURU stated, 'It is gratifying to see that the clinical and economic benefits of Altrazeal® are being recognized and that Altrazeal® will have been launched in many important international markets by year-end 2013. It will indeed be an important and significant milestone when the Company generates positive cash flow.'"
High tight flag?
Of course, patterns are trickier with low-priced stocks.
oops, sorry, was referring to MBLX.
High tight flag?